Allergy Therapeutics (GB:AGY) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Allergy Therapeutics PLC has released its Annual Report for the financial year ending June 2024 and announced proposals for special incentive awards to boost share price growth. The company plans to implement long-term incentive awards for its senior executives and additional options for employees, while also proposing to repurchase and cancel deferred shares. Shareholders’ approval is sought for these moves, which aim to enhance shareholder value.
For further insights into GB:AGY stock, check out TipRanks’ Stock Analysis page.
